Abstract
Purpose
Conjunctival melanoma is a rare tumor worldwide and is extremely rare among black population. This study aims to report the demographics, clinical presentation, treatment, and outcome of patients seen in an indigenous black population in Southwestern Nigeria.
Methods
All patients histologically diagnosed with conjunctival melanoma and managed in the facility were reviewed. Their demographics, clinical presentation, treatment received, outcome of treatment, and histopathological features were analyzed.
Results
Six patients (males = 2) with a mean age of 49.8 years were managed over 11 years (range 25–75 years). The right eye was involved in three patients, while one patient had bilateral non-simultaneous tumor. All six patients presented with pigmented growth over the ocular surface of varying duration, confirmed as malignant melanoma at histopathology after an excision biopsy (two patients), incision biopsy (one patient), or orbital exenteration (three patients). One patient who had complete adjuvant treatment postoperatively remained alive and tumor-free at 7-year follow-up, one patient is presently on chemotherapy, one patient died while on admission, and the remaining three patients abandoned further postoperative treatment and defaulted from follow-up.
Conclusion
Conjunctival melanoma is a rare ocular malignancy in Southwestern Nigeria, and patients present with advanced disease with potential poor outcome.
References
Char DH (1980) The management of lid and conjunctival malignancies. Surv Ophthalmol 24:679–689
Keller AZ (1973) Histology, survivorship and related factors in the epidemiology of eye cancers. Am J Epidemiol 97:386–393
Scotto J, Fraumneni JF, Lee JA (1976) Melanomas of the eye and other noncutaneous sites: epidemiologic aspects. J Natl Cancer Inst 56:489–491
Osterlind A (1987) Trends in incidence of ocular malignant melanoma in Denmark 1943–1982. Int J Cancer 40:161–164
Grossniklaus HE, Green WR, Luckenbach M, Chan CC (1987) Conjunctival lesions in adults. A clinical and histopathologic review. Cornea 6:78–116
Charles NC, Stenson S, Taterka HB (1979) Epibulbar malignant melanoma in a black patient. Arch Ophthalmol 97:316–318
Kielar RA (1972) Limbal melanoma in a Negro. Arch Ophthalmol 87:392–395
Welsh NH, Jhatery Y (1971) Malignant melanoma of the cornea in an African patient. Am J Ophthalmol 72:796–800
Schwab L, Green WR (1987) Conjunctival melanoma in Africa. Ophthalmic Surg 18(12):900–903
Morris GC, Horn R (1951) Malignant melanoma in the Negro: review of the literature and report of nine cases. Surgery 29:223–230
Bishop EL (1932) Melanoma in the Negro. Am J Cancer 16:552
Miller B, Abraham C, Cole GC, Proctor NS (1981) Ocular malignant melanoma in South African blacks. Br J Ophthalmol 65:720–722
Seregard S (1998) Conjunctival melanoma. Surv Ophthalmol 42(4):321–350
Lewis MG (1967) Possible immunological factors in human malignant melanoma in Uganda (preliminary communication). Lancet 290:921–992
Levene A (1971) Sunlight and melanomas. Lancet 297(7704):855
Singh AD, Campos OE, Rhatigan RM, Schulman JA, Misra RP (1998) Conjunctival melanoma in the black population. Surv Ophthalmol 43(2):127–133
De Potter P, Shields CL, Shields JA, Menduke H (1993) Clinical predictive factors for development of recurrence and metastasis in conjunctival melanoma: a review of 68 cases. Br J Ophthalmol 77:624–630
Liesegang TJ, Campbell RJ (1980) Mayo clinic experience with conjunctival melanoma. Arch Ophthalmol 98:1385–1389
Bernardino VB, Naidoff MA, Clark WH (1976) Malignant melanomas of the conjunctiva. Am J Ophthalmol 82:383–394
Seregard S, Kock E (1992) Conjunctival malignant melanoma in Sweden 1969–91. Acta Ophthalmol 72:289–296
Shields CL, Shields JA, Gunduz K, Cater J, Mercado GV, Gross N, Lally B (2000) Conjunctival melanoma. Risk factors for recurrence, exenteration, metastasis and death in 150 consecutive patients. Arch Ophthalmol 118:1497–1507
Krementz ET, Sutherland CM, Carter RD, Ryan RF (1976) Malignant melanoma in the American black. Ann Surg 183:533–541
Templeton MD (1967) Tumors of the eye and adnexa in Africans of Uganda. Cancer 20:1689–1698
Swerdlow AJ, Cooke RR, Skegg DC, Wilkinson J (1995) Cancer incidence in England and Wales and New Zealand and in migrants between the two countries. Br J Cancer 72:326–343
Fasina O (2015) Ocular surface squamous neoplasia in Ibadan, Nigeria. Asian J Oncol 1:101–105
Muccioli C, Belfort R, Burnier M, Rao N (1996) Squamous cell carcinoma in a patient with the acquired immunodeficiency syndrome. Am J Ophthalmol 121:94–96
Tucker NA, Kroll S, Frigillana H, Obrien J, Gordon K, Char D (1994) Immunohistochemical detection of p53 in primary acquired melanosis and melanoma of the conjunctiva (abstract). Invest Ophthalmol Vis Sci 35(Suppl):1722
Royds JA, Sharrard RM, Parsons MA, Lawry J, Rees R, Cottam D, Wagner B, Rennie IG (1992) C-myc oncogene expression in ocular melanomas. Graefe Arch Clin Exp Ophthalmol 230:366–371
Halachmi S, Gilchrest BA (2001) Update on genetic events in the pathogenesis of melanoma. Curr Opin Oncol 13(2):129–136
Folberg R (1993) Tumor progression in ocular melanoma. J Invest Dermatol 100:326S–331S
Betharia SM, Vashisht S, Kalra BR (1985) Malignant melanoma of the conjunctiva following surgical excision of naevus. Indian J Ophthalmol 33(4):259–261
Reintgen DS, McCarty KMJ, Cox E, Seigler HF (1982) Malignant melanoma in black American and white American populations. A comparative review. JAMA 248:1856–1859
Hudson DA, Krige JE (1995) Melanoma in black South Africans. J Am Coll Surg 180:65–71
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Ethical approval
All procedures performed in this study were in accordance with the 1964 Declaration of Helsinki and its later amendments.
Informed consent
Informed consent was obtained from all individual participants included in this study.
Rights and permissions
About this article
Cite this article
Fasina, O., Oluwasola, O.A. Conjunctival melanoma in Southwestern Nigeria: a case series and review of literature. Int Ophthalmol 38, 1747–1752 (2018). https://doi.org/10.1007/s10792-017-0612-5
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10792-017-0612-5